BioCentury
ARTICLE | Clinical News

Abemaciclib: Final Ph II neoMONARCH data

January 27, 2017 4:31 AM UTC

Final data from the open-label, international Phase II neoMONARCH trial in 224 postmenopausal women with previously untreated, early stage hormone receptor-positive, HER2-negative breast cancer showed...